| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 318 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 318 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 318 |
| 3 | CARBOPLATIN | 265 |
| 4 | PALBOCICLIB | 242 |
| 5 | METHOTREXATE SODIUM | 236 |
| 6 | CYTARABINE | 235 |
| 7 | PREDNISONE | 221 |
| 8 | ETOPOSIDE | 210 |
| 9 | DOXORUBICIN | 209 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACETAMINOPHEN 500 MG AND DIPHENHYDRAMINE HCL 25 MG | 1 | 0.0833 |
| 1 | TAGRAXOFUSP | 14 | 0.0260 |
| 2 | IDARUBICIN HYDROCHLORIDE | 22 | 0.0190 |
| 3 | INOTUZUMAB OZOGAMICIN | 45 | 0.0150 |
| 4 | PORFIMER SODIUM | 5 | 0.0147 |
| 5 | IBUPROFEN AND DIPHENHYDRAMINE HCL | 1 | 0.0139 |
| 6 | NADOFARAGENE FIRADENOVEC-VNCG | 5 | 0.0096 |
| 7 | FENBENDAZOLE | 1 | 0.0093 |
| 8 | SACCHAROMYCES CEREVISIAE | 7 | 0.0076 |
| 9 | DESMOPRESSIN ACETATE | 25 | 0.0066 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 521 |
| 1 | Alkylating Drug [EPC] | 518 |
| 2 | Platinum-based Drug [EPC] | 446 |
| 3 | Kinase Inhibitor [EPC] | 425 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 410 |
| 5 | Microtubule Inhibitor [EPC] | 241 |
| 6 | Topoisomerase Inhibitor [EPC] | 221 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 184 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 180 |
| 9 | Aromatase Inhibitor [EPC] | 167 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 14 | 0.0260 |
| 1 | CD22-directed Immunoconjugate [EPC] | 45 | 0.0150 |
| 2 | Actinomycin [EPC] | 10 | 0.0045 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 7 | 0.0033 |
| 4 | Recombinant Human Growth Hormone [EPC] | 71 | 0.0032 |
| 5 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 6 | Topoisomerase Inhibitor [EPC] | 221 | 0.0029 |
| 7 | CD33-directed Immunoconjugate [EPC] | 10 | 0.0027 |
| 8 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 4 | 0.0022 |
| 9 | Provitamin D2 Compound [EPC] | 64 | 0.0022 |